[Studies on the fibrinolytic therapy in the patients with nephrotic syndrome (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D005260:Female; D005341:Fibrinolysin; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000097:blood* / Q000188:drug therapy; D051381:Rats; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage
D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator